The TCS Advanced Drug Development (ADD) platform will exhibit at the upcoming SCOPE Summit Europe Conference in Barcelona, Spain, on 17-18 September, 2019. At the event, TCS will demonstrate its capability and platform advancements in the areas of drug development, clinical trials and centralized monitoring.
Additionally, the company will feature at the Clinical Research News European Innovation Awards as finalists. TCS is the only organization to have four entries among the final 14 nominations. The awards seek to recognize outstanding examples of applied strategic innovation – partnerships, deployment and collaborations that have manifestly improved the clinical trials process.
Four TCS nominations among 14 finalists SCOPE | Clinical Research News European Innovation Awards